RMD 4.36% $29.90 resmed inc

Ann: ResMed Announces Results for the Fourth Quarter of FY2023, page-171

  1. 201 Posts.
    lightbulb Created with Sketch. 9
    Resmed is now on a PE of 25 which previously it has been consistently in the 30's. These shares have been oversold and provide a great long term opportunity. The shorters will be burned in due time.

 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.